[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-344378-105":59,"doc-detail-344378-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-regulatory-roles-of-rna-binding-proteins-in-the-tumour-immune-microenvironment-of-gastrointestinal-malignancies","The regulatory roles of RNA-binding proteins in the tumour immune microenvironment of gastrointestinal malignancies","","The crosstalk between the tumour immune microenvironment (TIME) and tumour cells drives immune evasion and resistance to immunotherapy in gastrointestinal (GI) cancers. Post-transcriptional regulation is pivotal to GI tumour progression, with RNA-binding proteins (RBPs) controlling gene expression through RNA-binding domains and m6A-related recognition. Aberrant RBP activity, including HuR and YBX1, promotes immune escape and worsens prognosis. Although RBP targeting is promising, mechanisms linking RBPs to TIME regulation remain insufficiently understood.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-regulatory-roles-of-rna-binding-proteins-in-the-tumour-immune-microenvironment-of-gastrointestinal-malignancies/344378/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-regulatory-roles-of-rna-binding-proteins-in-the-tumour-immune-microenvironment-of-gastrointestinal-malignancies/344378.png","ImageObject",300,407,{"name":92,"@type":93},"Aurelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-26","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How do tumour immune microenvironment and tumour cells influence immunotherapy outcomes in gastrointestinal cancers?","Question",{"text":112,"@type":113},"Interactions between the tumour immune microenvironment (TIME) and tumour cells promote immune evasion and resistance, leading to relapse in many patients receiving immunotherapy.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What roles do RNA-binding proteins play in post-transcriptional regulation relevant to GI tumours?",{"text":117,"@type":113},"RNA-binding proteins regulate gene expression by binding mRNAs and noncoding RNAs and, in particular, by acting as readers of m6A-modified RNAs, thereby affecting malignant transformation.",{"name":119,"@type":110,"acceptedAnswer":120},"Why is targeting RNA-binding proteins considered promising, and what is still unclear?",{"text":121,"@type":113},"Targeting RBPs may improve immunotherapy efficacy in GI cancers, but the precise mechanisms by which RBPs regulate the TIME remain poorly understood and are still at an early therapeutic stage.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},344378,1790145509,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514068365,"https://ap-avatar.wpscdn.com/avatar/10000253d8d9f28188e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1794309523707217728","REVIEW  \nThe regulatory roles of RNA-binding proteins in the tumour immune microenvironment of gastrointestinal malignancies  \nDongqi Lia *, Xiangyu Chub*, Weikang Liua, Yongsu Maa, Xiaodong Tiana, and Yinmo Yanga  \naDepartment of Hepatobiliary and Pancreatic Surgery, Peking University First Hospital, Beijing, China; bDepartment of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, China  \nABSTRACT  \nThe crosstalk between the tumour immune microenvironment (TIME) and tumour cells promote immune evasion and resistance to immunotherapy in gastrointestinal (GI) tumours. Post-transcriptional regulation of genes is pivotal to GI tumours progression, and RNA-binding proteins (RBPs) serve as key regulators via their RNA-binding domains. RBPs may exhibit either anti-tumour or protumour functions by influencing the TIME through the modulation of mRNAs and non-coding RNAs expression, as well as post-transcriptional modifications, primarily N6-methyladenosine (m6A) . Aberrant regulation of RBPs, such as HuR and YBX1, typically enhances tumour immune escape and impacts prognosis of GI tumour patients. Further, while targeting RBPs offers a promising strategy for improving immunotherapy in GI cancers, the mechanisms by which RBPs regulate the TIME in these tumours remain poorly understood, and the therapeutic application is still in its early stages. This review summarizes current advances in exploring the roles of RBPs in regulating genes expression and their effect on the TIME of GI tumours, then providing theoretical insights for RBPtargeted cancer therapies.  \nARTICLE HISTORY  \nRevised 3 November 2024 Accepted 4 December 2024  \nKEYWORDS  \nRNA binding protein; mRNAs; ncRNAs; tumour immune microenvironment; immunotherapy; targeted therapy  \n1. Introduction  \nGastrointestinal (GI) cancers represent a group of malignancies with high incidence and mortality, which impose a significant global health burden [ 1,2] . The tumour immune microenvironment (TIME), comprising various immune cell populations from both innate and adaptive immunity along with immune regulatory factors, plays a critical role in tumour progression [3,4] . Recent studies have highlighted the strong correlation between TIME and clinical outcomes in patients with cancers. Immunotherapy has emerged as a promising treatment for GI tumours, and quickly gains prominence in the field of oncology [5–7] . However, a major challenge is that many patients undergoing immunotherapy develop resistance and experience rapid relapse, largely due to the interactions between GI tumours and the TIME, which are mediated by immunosuppressive elements like programmed cell death ligand 1-positive (PD-L1+) exosomes [8,9] .  \nRNA-binding proteins (RBPs) are a highly conserved class of proteins essential for post-transcriptional regulation of genes [ 10] . They recognize mRNAs and noncoding RNAs (ncRNAs), or function as readers of N6-methyladenosine (m6A)-modified RNAs, to contribute to the malignant transformation of cancer cells (Figure 1) [ 11, 12] . Notably, RBPs bind to RNAs through RNA-binding  \ndomains (RBDs) such as K homology (KH) domains, RNA recognition motifs, and zinc finger domains, forming intricate and overlapping post-transcriptional RNA regulons [ 13] . As a result, RBPs regulate oncogenes and tumour suppressor genes, influencing the TIME to promote GI tumours progression (Figure 2) [ 14] . In this review, we focus on the roles of RBPs in modulating the TIME in GI tumours, and explore the potential of targeting RBPs to enhance the efficacy of immunotherapy.  \n2. Dysregulation and dysfunction of RBPs in TIME  \nRBPs are primarily involved in the post-translational modification of RNAs, and any minor changes in RBPs affect downstream signalling pathways [ 15] . Therefore, dysregulation of RBPs is a driving force in the malignant transformation of tumour cells. RBPs are critical elements in transporting mRNAs from the nucleus to the cytoplasm, and both ","cbCairvuicvvLoJf","https://ap.wps.com/l/cbCairvuicvvLoJf","pdf",5330858,14,"English","# 1. Introduction\n## Gastrointestinal cancers and the role of TIME\n## RNA-binding proteins and post-transcriptional regulation\n# 2. Dysregulation and dysfunction of RBPs in TIME\n## Post-translational RNA regulation and signalling effects\n## mRNA transport and translational control\n## Examples of RBP-mediated regulation (e.g., Pumilio)\n# Figures\n## Figure 1. Post-transcriptional regulation by RBPs\n## Figure 2. RBP-mediated regulation of the TIME","[{\"question\":\"How do tumour immune microenvironment and tumour cells influence immunotherapy outcomes in gastrointestinal cancers?\",\"answer\":\"Interactions between the tumour immune microenvironment (TIME) and tumour cells promote immune evasion and resistance, leading to relapse in many patients receiving immunotherapy.\"},{\"question\":\"What roles do RNA-binding proteins play in post-transcriptional regulation relevant to GI tumours?\",\"answer\":\"RNA-binding proteins regulate gene expression by binding mRNAs and noncoding RNAs and, in particular, by acting as readers of m6A-modified RNAs, thereby affecting malignant transformation.\"},{\"question\":\"Why is targeting RNA-binding proteins considered promising, and what is still unclear?\",\"answer\":\"Targeting RBPs may improve immunotherapy efficacy in GI cancers, but the precise mechanisms by which RBPs regulate the TIME remain poorly understood and are still at an early therapeutic stage.\"}]","The regulatory roles of RNA-binding proteins in the tumour immune microenvironment of gastrointestinal malignancies | PDF",1790053522,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/da76d8c97228309d74edd9ab932b3710.webp",983,1280,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/efa342b9fb7d2a46eb2f1764d2477a81.webp",982,1278,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ade9905e1b714dc9aeae32ef9ba117d3.webp",981,1277,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/41679f12b9aec71cb167ae023675ff50.webp",980,1276]